| MolName | N-[2-[(5Z)-5-benzylidene-2,4-dioxo-1,3-thiazolidin-3-yl]ethyl]-6-oxo-4,5-dihydro-1H-pyridazine-3-carboxamide |
| MolecularFormula | C17H16N4O4S |
| Smiles | O=C(C(CC1)=NNC1=O)NCCN(C(/C(/S1)=C/c2ccccc2)=O)C1=O |
| InChI | InChI=1S/C17H16N4O4S/c22-14-7-6-12(19-20-14)15(23)18-8-9-21-16(24)13(26-17(21)25)10-11-4-2-1-3-5-11/h1-5,10H,6-9H2,(H,18,23)(H,20,22) |
| InChIK | PGFUIRWXIPZSIN-UHFFFAOYSA-N |
| TotalMolweight | 372.404 |
| Molweight | 372.404 |
| MonoisotopicMass | 372.089226 |
| CLogP | 0.4457 |
| CLogS | -3.473 |
| H Acceptors | 8 |
| H Donors | 2 |
| TotalSurfaceArea | 270.69 |
| Relative PSA | 0.39761 |
| PolarSurfaceArea | 133.24 |
| Druglikeness | 8.1543 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | limit! methylene-thiazolidine-2,4-dione |
| Shape Index | 0.65385 |
| Fragments | 1 |
| Non HAtoms | 26 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 5 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 5 |
| Symmetricatoms | 2 |
| Amides | 2 |
| StereoCon |
Click to Load Molecule:
1 - N-[2-[(5Z)-5-benzylidene-2,4-dioxo-1,3-thiazolidin-3-yl]ethyl]-6-oxo-4,5-dihydro-1H-pyridazine-3-carboxamide | 2 - N-[2-[(5Z)-5-benzylidene-2,4-dioxo-1,3-thiazolidin-3-yl]ethyl]-6-oxo-4,5-dihydro-1H-pyridazine-3-carboxamide